XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
270 hedge funds and large institutions have $6.72B invested in Acceleron Pharma in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 90 increasing their positions, 83 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less capital invested
Capital invested by funds: $7.3B → $6.72B (-$584M)
43% less call options, than puts
Call options by funds: $24.9M | Put options by funds: $43.9M
Holders
270
Holding in Top 10
9
Calls
$24.9M
Puts
$43.9M
Top Buyers
| 1 | +$55.2M | |
| 2 | +$43.9M | |
| 3 | +$33.3M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$32M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.3M |
Top Sellers
| 1 | -$116M | |
| 2 | -$59.4M | |
| 3 | -$30.1M | |
| 4 |
BlackRock
New York
|
-$28.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.9M |